CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 143 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $482,000 | +66.2% | 83,800 | +33.0% | 0.01% | +80.0% |
Q1 2021 | $290,000 | -3.0% | 63,000 | -29.6% | 0.01% | -16.7% |
Q4 2020 | $299,000 | -3.5% | 89,500 | -14.3% | 0.01% | -14.3% |
Q3 2020 | $310,000 | +62.3% | 104,400 | +152.2% | 0.01% | +75.0% |
Q2 2020 | $191,000 | +20.1% | 41,400 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $159,000 | – | 41,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |